T. Rowe Price Associates’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $242K | Buy |
|
|||||
|
2023
Q4 | $216K | Buy |
|
|||||
|
2023
Q3 | $150K | Buy |
|
|||||
|
2023
Q2 | $146K | Sell |
|
|||||
|
2023
Q1 | $9.27M | Sell |
|
|||||
|
2022
Q4 | $10.2M | Sell |
|
|||||
|
2022
Q3 | $13.3M | Buy |
|
|||||
|
2022
Q2 | $1.93M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $3.04M | Sell |
|
|||||
|
2021
Q3 | $15.3M | Sell |
|
|||||
|
2021
Q2 | $19M | Sell |
|
|||||
|
2021
Q1 | $52.4M | Sell |
|
|||||
|
2020
Q4 | $67.1M | Sell |
|
|||||
|
2020
Q3 | $61M | Sell |
|
|||||
|
2020
Q2 | $91.9M | Buy |
|
|||||
|
2020
Q1 | $60.8M | Sell |
|
|||||
|
2019
Q4 | $105M | Buy |
|
|||||
|
2019
Q3 | $16.1M | Buy |
|